Showing results (171-180 of 191) with videos related to
Sort By:
Pageof 20
The American Journal of Psychiatry|September 10, 2016
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical TrialsBret R Rutherford, Melanie M Wall, Patrick J Brown, et al.Plos One|January 5, 2011
Placebos without deception: a randomized controlled trial in irritable bowel syndromeTed J Kaptchuk, Elizabeth Friedlander, John M Kelley, et al.Plos One|October 31, 2012
Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndromeKathryn T Hall, Anthony J Lembo, Irving Kirsch, et al.Brain and Behavior|February 28, 2015
Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patientsKathryn T Hall, Benjamin R Tolkin, Garrett M Chinn, et al.Pain|February 19, 2021
Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trialAnthony Lembo, John M Kelley, Judy Nee, et al.Neuroimage. Clinical|June 6, 2018
Enhancing treatment of osteoarthritis knee pain by boosting expectancy: A functional neuroimaging studyJian Kong, Zengjian Wang, Jaclyn Leiser, et al.BMJ (Clinical Research Ed.)|February 3, 2006
Sham device v inert pill: randomised controlled trial of two placebo treatmentsTed J Kaptchuk, William B Stason, Roger B Davis, et al.Trials|May 27, 2017
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trialSarah Ballou, Ted J Kaptchuk, William Hirsch, et al.Science Advances|October 22, 2020
Dynamic brain-to-brain concordance and behavioral mirroring as a mechanism of the patient-clinician interactionDan-Mikael Ellingsen, Kylie Isenburg, Changjin Jung, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2014
Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular diseaseKathryn T Hall, Christopher P Nelson, Roger B Davis, et al.Pageof 20